Caplin Point Laboratories informs about press release

08 Aug 2024 Evaluate
Caplin Point Laboratories has attached a Press Release regarding grant of final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Timolol Maleate Ophthalmic Solution USP, 0.5% (Eye drops), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) TIMOPTIC, from Bausch and Lomb Inc, to its Subsidiary Caplin Steriles. 

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1709.00 -23.65 (-1.36%)
24-Feb-2026 14:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1732.80
Dr. Reddys Lab 1303.75
Cipla 1326.60
Zydus Lifesciences 901.50
Lupin 2242.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×